Intersect ENT
XENT
#6045
Rank
โ‚ฌ0.81 B
Marketcap
24,06ย โ‚ฌ
Share price
0.00%
Change (1 day)
5.39%
Change (1 year)

Revenue for Intersect ENT (XENT)

Revenue in 2021: โ‚ฌ90.93 Million

According to Intersect ENT's latest financial reports the company's current revenue (TTM ) is โ‚ฌ90.93 Million. In 2021 the company made a revenue of โ‚ฌ90.93 Million an increase over the revenue in the year 2020 that were of โ‚ฌ68.61 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Intersect ENT from 2012 to 2021

Annual revenue

Year Revenue Change
2021โ‚ฌ90.93 M32.52%
2020โ‚ฌ68.61 M-26.19%
2019โ‚ฌ92.97 M0.62%
2018โ‚ฌ92.39 M12.64%
2017โ‚ฌ82.03 M22.35%
2016โ‚ฌ67.04 M27.79%
2015โ‚ฌ52.46 M59.62%
2014โ‚ฌ32.86 M115.2%
2013โ‚ฌ15.27 M205.83%
2012โ‚ฌ4.99 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Ocular Therapeutix
OCUL
โ‚ฌ47.51 M-47.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Anika Therapeutics
ANIK
โ‚ฌ68.92 M-24.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Haemonetics
HAE
โ‚ฌ1.13 B 1,143.91%๐Ÿ‡บ๐Ÿ‡ธ USA
ICON plc
ICLR
โ‚ฌ6.90 B 7,490.40%๐Ÿ‡ฎ๐Ÿ‡ช Ireland